Jessica Hagen
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
The company also announced a new payer network and revenue cycle management service.
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
The acquisition expands the senior-focused company's offerings to include a workflow management program and value-based care reimbursement assistance.
Fire1, a remote patient monitoring company for heart failure patients, and Protai, an AI-powered drug discovery platform, scored funding.
The platform connects adults with conditions like autism, ADHD, OCD or Tourette's with care teams trained to help with their specific needs.
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
The startup's technology allows telehealth companies and virtual medical clinics to verify a patient's health insurance coverage manually or programmatically.
René Quashie, vice president of digital health at the Consumer Technology Association, discusses the CTA's report on consumer adoption of digital health products.
Viz.ai also announced an agreement with Bristol Myers Squibb to identify patients with hypertrophic cardiomyopathy.